Current pharmacologic treatments include mainly anti-vascular endothelial growth factor (VEGF) and corticosteroids administered via intravitreal (IVT) injections which have become the first-line treatment for many retinal diseases [3]. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.